When action movie star Chuck Norris earlier this month filed suit against firms involved in the distribution of gadolinium-based contrast agents, he put a human face on the gadolinium retention issue. MRI safety expert Dr. Emanuel Kanal of the University of Pittsburgh discusses the latest findings in what's known about gadolinium safety in this video.
Correction, Kanal Video 1 My MistakeVideo from RSNA 2017: Gadolinium retention debate takes center stage
Nov 28, 2017
Latest in Home
Neiman index outperforms Charlson for predicting imaging use
December 20, 2024
40% of women in their 40s forgo biennial breast cancer screening
December 20, 2024
Practices must comply with the Corporate Transparency Act
December 20, 2024
